Stay updated on AK104 in MSI-H/dMMR Gastro/Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the AK104 in MSI-H/dMMR Gastro/Colorectal Cancer Clinical Trial page.

Latest updates to the AK104 in MSI-H/dMMR Gastro/Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial is now titled “Perioperative Cadonilimab (AK104) in Locally Advanced MSI-H/dMMR Gastric or Gastroesophageal Junction and Colorectal Adenocarcinoma,” and the listed organization changed to Peking University Cancer Hospital & Institute. A new record version was posted with updates across study identification, status, description, sponsors, arms and interventions, outcome measures, and eligibility.SummaryDifference2%

- Check11 days agoChange DetectedThe site footer now identifies the website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears on the page, and the site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1.0%

- Check39 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov interface as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history gains a new revision entry for v3.7.0 and removes the previous v3.6.6 entry, updating the history to reflect the latest submitted version.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.6.6 was added to the history, replacing v3.6.5. This indicates a new page version; it reflects an underlying update to the record display rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to AK104 in MSI-H/dMMR Gastro/Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in MSI-H/dMMR Gastro/Colorectal Cancer Clinical Trial page.